No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional study

BackgroundPrimary liver cancer (PLC) is one of the most common cancers worldwide. ABO blood groups and rhesus (Rh) factor are inherited characteristics. Their association with the presence of PLC remains unclear in cirrhotic patients. Hence, the purpose of this cross-sectional study was to evaluate...

Full description

Saved in:
Bibliographic Details
Main Authors: Liyan Dong, Yuhang Yin, Huiyuan Lu, Di Sun, Dongyang Wang, Deli Zou, Xingshun Qi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1432137/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591951444049920
author Liyan Dong
Liyan Dong
Yuhang Yin
Yuhang Yin
Huiyuan Lu
Huiyuan Lu
Di Sun
Di Sun
Dongyang Wang
Deli Zou
Xingshun Qi
author_facet Liyan Dong
Liyan Dong
Yuhang Yin
Yuhang Yin
Huiyuan Lu
Huiyuan Lu
Di Sun
Di Sun
Dongyang Wang
Deli Zou
Xingshun Qi
author_sort Liyan Dong
collection DOAJ
description BackgroundPrimary liver cancer (PLC) is one of the most common cancers worldwide. ABO blood groups and rhesus (Rh) factor are inherited characteristics. Their association with the presence of PLC remains unclear in cirrhotic patients. Hence, the purpose of this cross-sectional study was to evaluate whether blood groups were risk factors for the presence of PLC in cirrhosis.MethodsPatients with liver cirrhosis who were consecutively admitted to the Department of Gastroenterology of the General Hospital of Northern Theater Command from 1 January 2010 to 30 June 2014 were retrospectively screened. Logistic regression analyses were performed to explore the association of ABO blood groups and Rh factor with PLC in cirrhotic patients. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were calculated after adjusting for gender, age, family history of liver cirrhosis, HBV-DNA positivity, and etiology of cirrhosis. Subgroup analyses were performed according to the etiology of liver cirrhosis.ResultsOverall, 1,158 cirrhotic patients without PLC and 240 cirrhotic patients with PLC were included in the study. After adjusting for confounding factors, non-O (aOR = 0.763; 95%CI = 0.449–1.298, p = 0.319), A (aOR = 0.643; 95%CI = 0.332–1.246, p = 0.191), B (aOR = 0.835; 95%CI = 0.453–1.540, p = 0.564), AB (aOR = 0.888; 95%CI = 0.363–2.170, p = 0.795), and Rh (+) (aOR = 0.239; 95%CI = 0.036–1.571, p = 0.136) blood groups were not independently associated with PLC in cirrhotic patients. In the subgroup analysis of HBV-related cirrhotic patients, the proportion of A blood group was significantly lower in cirrhotic patients with PLC than in those without PLC (24.17% vs. 33.99%, p < 0.001); however, in HCV- and alcohol-related cirrhotic patients, the proportions of ABO blood groups and Rh factor were not significantly different between the two groups.ConclusionABO blood groups and Rh factor may not be associated with the presence of PLC in cirrhotic patients.
format Article
id doaj-art-26119dee85f943698706b74be8476a6f
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-26119dee85f943698706b74be8476a6f2025-01-22T04:11:12ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.14321371432137No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional studyLiyan Dong0Liyan Dong1Yuhang Yin2Yuhang Yin3Huiyuan Lu4Huiyuan Lu5Di Sun6Di Sun7Dongyang Wang8Deli Zou9Xingshun Qi10Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, ChinaPostgraduate College, China Medical University, Shenyang, ChinaDepartment of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, ChinaPostgraduate College, China Medical University, Shenyang, ChinaDepartment of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, ChinaPostgraduate College, Shenyang Pharmaceutical University, Shenyang, ChinaDepartment of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, ChinaPostgraduate College, Dalian Medical University, Dalian, ChinaDepartment of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, ChinaDepartment of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, ChinaDepartment of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, ChinaBackgroundPrimary liver cancer (PLC) is one of the most common cancers worldwide. ABO blood groups and rhesus (Rh) factor are inherited characteristics. Their association with the presence of PLC remains unclear in cirrhotic patients. Hence, the purpose of this cross-sectional study was to evaluate whether blood groups were risk factors for the presence of PLC in cirrhosis.MethodsPatients with liver cirrhosis who were consecutively admitted to the Department of Gastroenterology of the General Hospital of Northern Theater Command from 1 January 2010 to 30 June 2014 were retrospectively screened. Logistic regression analyses were performed to explore the association of ABO blood groups and Rh factor with PLC in cirrhotic patients. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were calculated after adjusting for gender, age, family history of liver cirrhosis, HBV-DNA positivity, and etiology of cirrhosis. Subgroup analyses were performed according to the etiology of liver cirrhosis.ResultsOverall, 1,158 cirrhotic patients without PLC and 240 cirrhotic patients with PLC were included in the study. After adjusting for confounding factors, non-O (aOR = 0.763; 95%CI = 0.449–1.298, p = 0.319), A (aOR = 0.643; 95%CI = 0.332–1.246, p = 0.191), B (aOR = 0.835; 95%CI = 0.453–1.540, p = 0.564), AB (aOR = 0.888; 95%CI = 0.363–2.170, p = 0.795), and Rh (+) (aOR = 0.239; 95%CI = 0.036–1.571, p = 0.136) blood groups were not independently associated with PLC in cirrhotic patients. In the subgroup analysis of HBV-related cirrhotic patients, the proportion of A blood group was significantly lower in cirrhotic patients with PLC than in those without PLC (24.17% vs. 33.99%, p < 0.001); however, in HCV- and alcohol-related cirrhotic patients, the proportions of ABO blood groups and Rh factor were not significantly different between the two groups.ConclusionABO blood groups and Rh factor may not be associated with the presence of PLC in cirrhotic patients.https://www.frontiersin.org/articles/10.3389/fmed.2024.1432137/fullABO blood groupsrhesus factorprimary liver cancerliver cirrhosisrisk factor
spellingShingle Liyan Dong
Liyan Dong
Yuhang Yin
Yuhang Yin
Huiyuan Lu
Huiyuan Lu
Di Sun
Di Sun
Dongyang Wang
Deli Zou
Xingshun Qi
No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional study
Frontiers in Medicine
ABO blood groups
rhesus factor
primary liver cancer
liver cirrhosis
risk factor
title No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional study
title_full No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional study
title_fullStr No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional study
title_full_unstemmed No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional study
title_short No association of ABO blood groups and Rh factor with primary liver cancer in cirrhotic patients: a single-center cross-sectional study
title_sort no association of abo blood groups and rh factor with primary liver cancer in cirrhotic patients a single center cross sectional study
topic ABO blood groups
rhesus factor
primary liver cancer
liver cirrhosis
risk factor
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1432137/full
work_keys_str_mv AT liyandong noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT liyandong noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT yuhangyin noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT yuhangyin noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT huiyuanlu noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT huiyuanlu noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT disun noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT disun noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT dongyangwang noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT delizou noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy
AT xingshunqi noassociationofabobloodgroupsandrhfactorwithprimarylivercancerincirrhoticpatientsasinglecentercrosssectionalstudy